Allogeneic bone marrow–derived mesenchymal stromal cells for hepatitis B virus–related acute‐on‐chronic liver failure: A randomized controlled trial - Lin, Bing‐liang; Chen, Jun‐feng; Qiu, Wei‐hong; Wang, Ke‐wei; Xie, Dong‐ying; Chen, Xiao‐yong; Liu, Qiu‐li; Peng, Liang; Li, Jian‐guo; Mei, Yong‐yu; Weng, Wei‐zhen; Peng, Yan‐wen; et al. (Hepatology (Baltimore, Md.), 2017)
Keywords: Acute-On-Chronic Liver Failure - etiology; Acute-On-Chronic Liver Failure - mortality; Acute-On-Chronic Liver Failure - physiopathology; Acute-On-Chronic Liver Failure - therapy; Adult; Bilirubin; Bone marrow; Cause of Death; China; Confidence intervals; Female; Fever; Hepatitis; Hepatitis B; Hepatitis B - complications; Hepatitis B - physiopathology; Hepatitis B virus - isolation & purification; Hepatology; Humans; Kaplan-Meier Estimate; Liver; Liver failure; Lymphocytes B; Male; Mesenchymal Stem Cell Transplantation - methods; Mesenchymal stem cells; Mesenchyme; Middle Aged; Mortality; Prognosis; Prospective Studies; Risk Assessment; Side effects; Statistics, Nonparametric; Stromal cells; Survival; Survival Analysis; Transplantation, Homologous; Treatment Outcome